- Home
- ADV vs RLAY Comparison
ADV vs RLAY Comparison
Compare ADV & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADV
- RLAY
- Stock Information
- Founded
- ADV 1987
- RLAY 2015
- Country
- ADV United States
- RLAY United States
- Employees
- ADV N/A
- RLAY N/A
- Industry
- ADV Business Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADV Consumer Discretionary
- RLAY Health Care
- Exchange
- ADV Nasdaq
- RLAY Nasdaq
- Market Cap
- ADV 977.6M
- RLAY 1.1B
- IPO Year
- ADV N/A
- RLAY 2020
- Fundamental
- Price
- ADV $3.44
- RLAY $4.64
- Analyst Decision
- ADV Strong Buy
- RLAY Strong Buy
- Analyst Count
- ADV 1
- RLAY 9
- Target Price
- ADV N/A
- RLAY $20.88
- AVG Volume (30 Days)
- ADV 537.8K
- RLAY 1.4M
- Earning Date
- ADV 11-07-2024
- RLAY 11-06-2024
- Dividend Yield
- ADV N/A
- RLAY N/A
- EPS Growth
- ADV N/A
- RLAY N/A
- EPS
- ADV N/A
- RLAY N/A
- Revenue
- ADV $3,990,708,000.00
- RLAY $10,006,000.00
- Revenue This Year
- ADV N/A
- RLAY N/A
- Revenue Next Year
- ADV $2.10
- RLAY N/A
- P/E Ratio
- ADV N/A
- RLAY N/A
- Revenue Growth
- ADV N/A
- RLAY N/A
- 52 Week Low
- ADV $2.60
- RLAY $4.48
- 52 Week High
- ADV $4.95
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- ADV 55.79
- RLAY 23.64
- Support Level
- ADV $3.05
- RLAY $5.96
- Resistance Level
- ADV $3.59
- RLAY $6.39
- Average True Range (ATR)
- ADV 0.28
- RLAY 0.34
- MACD
- ADV 0.02
- RLAY -0.12
- Stochastic Oscillator
- ADV 46.43
- RLAY 7.92
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is the provider of outsourced sales and marketing solutions to consumer goods companies and retailers. It has a technology-enabled platform of sales and marketing services like headquarter sales, retail merchandising, in-store sampling, digital commerce, and shopper marketing. For brands and retailers of all sizes, the firm helps to get the right products on the shelf and into the hands of consumers. The company helps its clients to sell more while spending less. Advantage has offices throughout North America and strategic investments in select markets throughout Africa, Asia, Australia, and Europe through which it services the global needs of multinational, regional, and local manufacturers. Its services are provided across two segments sales and marketing.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).